APOLLO ENDOSURGERY

apollo-endosurgery-logo

Apollo Endosurgery develops medical devices for the diagnosis and treatment of gastrointestinal diseases. The company’s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo’s products include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon. Apollo Endosurgery was ... founded upon the initial work of the Apollo Group, an international think tank of world-renowned gastroenterologists and surgeons from five leading universities (Mayo Clinic, Johns Hopkins, Medical University of South Carolina, University of Texas Medical Branch-Galveston and Chinese University-Hong Kong.) Disappointed with the pace of innovation in therapeutic flexible endoscopy, the Group assembled in 1998 (Timeline) with the goal to advance the new discipline; their specific focus was the use of long, flexible instruments deployed through a natural orifice in order to diagnose and potentially treat gastrointestinal disorders.

#SimilarOrganizations #People #Financial #Event #Website #More

APOLLO ENDOSURGERY

Industry:
Biotechnology Health Care Medical Device

Founded:
2006-01-01

Address:
Austin, Texas, United States

Country:
United States

Website Url:
http://www.apolloendo.com

Total Employee:
251+

Status:
Active

Contact:
+1 512 279 5105

Total Funding:
433.53 M USD

Technology used in webpage:
LetsEncrypt Amazon HSTS Apple Mobile Web App Capable Amazon Virginia Region Microsoft CloudFront Amazon Route 53 AWS Global Accelerator Smart App Banner


Similar Organizations

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

alung-technologies-logo

ALung Technologies

ALung Technologies develops medical gas exchange devices for the treatment of acute and chronic respiratory disorders.

impel-neuropharma-logo

Impel NeuroPharma

Impel NeuroPharma is a medical device company that develops a novel drug delivery device that uses direct nose-to-brain delivery.

intarcia-therapeutics-logo

Intarcia Therapeutics

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.

mercator-medsystems-logo

Mercator MedSystems

Mercator MedSystems develops site-specific delivery devices for the treatment of vascular, oncologic, and regenerative diseases.

mri-robotics-logo

MRI Robotics

MRI Robotics is dedicated to advanced medical devices for the diagnosis and treatment of cancer.

myomo-logo

Myomo

Myomo develops devices with myoelectric prosthetic technology to restore the mobility of individuals with muscle weakness.

nano-precision-medical-logo

Nano Precision Medical

Nano Precision Medical develops novel miniaturized subdermal implants

tandem-diabetes-care-logo

Tandem Diabetes Care

Tandem diabetes care provides products that empower both people with diabetes and those who care for them.


Current Advisors List

bruce-robertson_image

Bruce Robertson Board of Directors @ Apollo Endosurgery
Board_member

jack-nielsen_image

Jack Nielsen Member of the Board of Directors @ Apollo Endosurgery
Board_member

john-creecy_image

John Creecy Board Member @ Apollo Endosurgery
Board_member

Current Employees Featured

jeffrey-g-black_image

Jeffrey G. Black
Jeffrey G. Black Chief Financial Officer @ Apollo Endosurgery
Chief Financial Officer
2021-08-01

jeffrey-g-black_image

Jeffrey G. Black
Jeffrey G. Black Chief Financial Officer @ Apollo Endosurgery
Chief Financial Officer
2021-08-01

stefanie-cavanaugh_image

Stefanie Cavanaugh
Stefanie Cavanaugh CFO @ Apollo Endosurgery
CFO
2015-02-01

david-m-hooper_image

David M. Hooper
David M. Hooper Vice President- Quality and Regulatory Affairs @ Apollo Endosurgery
Vice President- Quality and Regulatory Affairs
2019-07-01

keely-scamperle_image

Keely Scamperle
Keely Scamperle VP of Reimbursement & Market Access @ Apollo Endosurgery
VP of Reimbursement & Market Access
2022-01-17

pankaj-pasricha_image

Pankaj Pasricha
Pankaj Pasricha Co-founder @ Apollo Endosurgery
Co-founder
2007-01-01

Founder


dennis-mcwilliams_image

Dennis McWilliams

Stock Details


Company's stock symbol is NASDAQ:APEN

Acquisitions List

Date Company Article Price
2016-09-08 LPATH LPATH acquired by Apollo Endosurgery N/A

Investors List

innovatus-capital-partners_image

Innovatus Capital Partners

Innovatus Capital Partners investment in Post-IPO Debt - Apollo Endosurgery

craig-hallum-capital-group_image

Craig-Hallum Capital Group

Craig-Hallum Capital Group investment in Post-IPO Debt - Apollo Endosurgery

ptv-sciences_image

PTV Healthcare Capital

PTV Healthcare Capital investment in Convertible Note - Apollo Endosurgery

athyrium-capital-management_image

Athyrium Capital Management LP

Athyrium Capital Management LP investment in Debt Financing - Apollo Endosurgery

ut-horizon-fund_image

UT Horizon Fund

UT Horizon Fund investment in Series C - Apollo Endosurgery

midcap-financial_image

MidCap Financial

MidCap Financial investment in Debt Financing - Apollo Endosurgery

east-west-bank_image

East West Bank

East West Bank investment in Debt Financing - Apollo Endosurgery

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Debt Financing - Apollo Endosurgery

ptv-sciences_image

PTV Healthcare Capital

PTV Healthcare Capital investment in Series B - Apollo Endosurgery

cpmg_image

CPMG

CPMG investment in Series B - Apollo Endosurgery

Official Site Inspections

http://www.apolloendo.com Semrush global rank: 2.25 M Semrush visits lastest month: 8.91 K

  • Host name: aa089eb6179d1ae2b.awsglobalaccelerator.com
  • IP address: 76.223.34.124
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Apollo Endosurgery"

» Company - Apollo Endo

Costa Rica Manufacturing Apollo Endosurgery Costa Rica S.R.L. Zone Franca Coyol, Edificio B13.3 Alajuela, Costa Rica. Tel: 011-506-4055-4000See details»

Investor Relations - Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. …See details»

Apollo Endosurgery to be Acquired by Boston …

Nov 29, 2022 Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a leading minimally invasive medical device company for gastrointestinal and bariatric procedures, announced today it has entered into a ...See details»

» about-us - Apollo Endo

© 2024 Apollo Endosurgery, Inc. All Rights Reserved. Code of Business Conduct and Ethics. Do not sell or share my personal information.. MKT-01085-00R07See details»

Apollo Endosurgery

It's time for a new approach to obesity. Boston Scientific offers the ESG Procedure, Orbera, and Apollo Revise. Learn more now.See details»

FDA Grants De Novo Marketing Authorization to Apollo …

Jul 13, 2022 4 World Health Organization, June 2021. 5 Centers for Disease Control and Prevention. ... [email protected]. Darrow Associates Investor Relations Matt …See details»

Apollo Endosurgery - LinkedIn

Apollo Endosurgery | 20,801 followers on LinkedIn. Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to …See details»

Apollo Endosurgery - PitchBook

Www.apolloendo.com. Formerly Known As. Neighborhood Connections Inc, JCG Inc, LPATH Inc, Jcginc. Ownership Status. Acquired/Merged (Operating Subsidiary) Financing Status. …See details»

Apollo Endosurgery - Overview, News & Similar companies

Apr 12, 2023 Apollo Endosurgery contact info: Phone number: (512) 279-5100 Website: www.apolloendo.com What does Apollo Endosurgery do? Apollo Endosurgery, Inc., a medical …See details»

Apollo Endosurgery Announces Two Important Milestones in the ...

Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that the MERIT …See details»

Apollo Endosurgery Announces CEO Transition | Nasdaq

Feb 8, 2021 Apollo Endosurgery, Inc. Stefanie Cavanaugh, [email protected]. Darrow Associates Investor Relations Matt Kreps, 214-597 …See details»

FDA Grants De Novo Marketing Authorization to Apollo

Jul 13, 2022 4 World Health Organization, June 2021. 5 Centers for Disease Control and Prevention. 6 Finkelstein E, et al. Obesity and Severe Obesity Forecasts Through 2030. 7 …See details»

Apollo Endosurgery Announces CEO Transition - Yahoo Finance

Feb 8, 2021 Will Transition to Accomplished Commercial and Operational Medtech Veteran Charles MckhannAUSTIN, TX / ACCESSWIRE / February 8, 2021 / Apollo Endosurgery, Inc. …See details»

Apollo ESG™ System – Boston Scientific

Endoscopic sleeve gastroplasty, or ESG, reduces the volume of the stomach with the Apollo ESG™ System. Under general anesthesia, a gastroenterologist or surgeon uses the Apollo …See details»

Apollo Endosurgery Announces CEO Transition - BioSpace

Feb 8, 2021 AUSTIN, TX / ACCESSWIRE / February 8, 2021 / Apollo Endosurgery, Inc., (“Apollo”) (NASDAQ:APEN), a global leader in next-generation minimally invasive medical …See details»

Apollo Endosurgery, Inc. Reports Record Endoscopy Revenue in …

Aug 3, 2021 AUSTIN, TX / ACCESSWIRE / August 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and …See details»

Apollo Endosurgery to Report Fourth Quarter and Full Year Results …

Feb 10, 2022 AUSTIN, TX / ACCESSWIRE / February 10, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally …See details»

» Overstitch™ Products - Apollo Endo

Advancing endolumenal procedures. OverStitch ™ supports procedures that depend on closure, apposition, or hemostasis of soft tissue in the upper and lower GI tract. OverStitch ™ …See details»

Apollo Endosurgery, Inc. Reports 33% U.S. Revenue Growth in First ...

May 3, 2022 Global revenue grew 20% year-over-year as adoption increased across all product linesAUSTIN, TX / ACCESSWIRE / May 3, 2022 / Apollo Endosurgery, Inc. ("Apollo") …See details»

linkstock.net © 2022. All rights reserved